Regentis Biomaterials Ltd

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Regentis Biomaterials Ltd
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Others were interested in
Frequently asked questions
You need to open and fund a Saxo account to buy Regentis Biomaterials Ltd stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for Regentis Biomaterials Ltd (by name) or ‘APPL’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for Regentis Biomaterials Ltd is RGNT:xase. You can use this code to find the stock in our platforms and track its price and performance.
Regentis Biomaterials Ltd has its primary listing on NYSE American. You can trade Regentis Biomaterials Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Regentis Biomaterials Ltd is available to trade on SaxoInvestor and SaxoTrader. You can buy Regentis Biomaterials Ltd stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Regentis Biomaterials Ltd or others.